Overview

Oracea Soolantra Association in Participants With Severe Rosacea

Status:
Completed
Trial end date:
2018-02-08
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the efficacy of Ivermectin 1% topical cream associated with Doxycycline 40 mg Modified release (MR) capsules versus Ivermectin 1% topical cream associated with Placebo in the treatment of severe Rosacea.
Phase:
Phase 4
Details
Lead Sponsor:
Galderma
Galderma R&D
Treatments:
Doxycycline
Ivermectin